Table 2 Recurrent or persistent health complaints at follow-up comparing participants with and without SARS-CoV-2 infection

Fever above 38 °C

20

5.8 (3.8–8.9)

0.92 (0.57–1.49)

274

6.3 (5.7–7.1)

reference

Cough

106

30.8 (26.1–35.9)

1.34 (1.04–1.71)

1073

24.8 (23.6–26.1)

reference

Shortness of breath

79

23.0 (18.8–27.7)

3.46 (2.56–4.68)

412

9.5 (8.7–10.4)

reference

Pain when breathing

16

4.7 (2.9–7.5)

2.36 (1.32–4.22)

80

1.9 (1.5–2.3)

reference

Chest pain

23

6.7 (4.5–9.9)

1.34 (0.84–2.12)

224

5.2 (4.6–5.9)

reference

Sore throat

89

25.9 (21.5–30.8)

0.95 (0.73–1.24)

1114

25.8 (24.5–27.1)

reference

Runny nose

132

38.4 (33.4–43.6)

0.98 (0.77–1.24)

1638

37.9 (36.5–39.4)

reference

Smell/taste disorders

44

12.8 (9.6–16.8)

4.11 (2.84–5.96)

147

3.4 (2.9–4.0)

reference

Loss of appetite

19

5.5 (3.5–8.5)

1.36 (0.82–2.26)

185

4.3 (3.7–4.9)

reference

Fatigue

127

36.9 (32.0–42.2)

1.76 (1.38–2.24)

1127

26.1 (24.8–27.4)

reference

Headaches

113

32.9 (28.2–38.1)

0.90 (0.70–1.15)

1485

34.4 (33.0–35.8)

reference

Dizziness

59

17.2 (13.5–21.5)

1.17 (0.86–1.59)

635

14.7 (13.7–15.8)

reference

Nausea/stomach upset

45

13.1 (9.9–17.1)

0.91 (0.65–1.28)

601

13.9 (12.9–15.0)

reference

Hot flushes/chills

37

10.8 (7.9–14.5)

0.80 (0.56–1.16)

516

11.9 (11.0–12.9)

reference

Sleep disorders

76

22.1 (18.0–26.8)

0.94 (0.71–1.24)

1004

23.2 (22.0–24.5)

reference

Myalgia and joint pain

75

21.9 (17.8–26.6)

1.53 (1.15–2.04)

652

15.1 (14.1–16.2)

reference

Numbness/burning/tingling in the feet/legs/hands

28

8.1 (5.7–11.6)

1.18 (0.78–1.84)

299

6.9 (6.2–7.7)

reference

Weakness in the legs

44

12.8 (9.6–16.8)

1.93 (1.32–2.80)

335

7.8 (7.0–8.6)

reference